CergenX is an AI-based invention in neonatal brain monitoring technology that identifies newborn infants who are at risk of brain injury.
CergenX has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
CergenX's investors include Enterprise Ireland.
CergenX is headquartered in Cork, Ireland.
CergenX is an AI-based invention in neonatal brain monitoring technology that identifies newborn infants who are at risk of brain injury.
CergenX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CergenX — Funding & Investors." VCBacked, June 10, 2023, https://www.vcbacked.co/company/cergenx. Accessed August 14, 2026.
VCBacked. (2023). CergenX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cergenx
{{cite web |title=CergenX — Funding & Investors |url=https://www.vcbacked.co/company/cergenx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated